Global Active Pharmaceutical Ingredient Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027
Date: Apr-2021 | Id: MACRC-58577 | Geographical Scope: Global | Publisher: Mnemonics Research
The global Active Pharmaceutical Ingredient market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on Mnemonics Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). By Market Verdors: Teva Novartis Pfizer Johnson & Johnson Mylan North China Pharmaceutical Group Dr. Reddy’s Laboratories Roche Aurobindo pharma Sun Pharmaceutical Industries Boehringer Ingelheim GmbH Bayer BASF DSM Zhejiang Medicine Biocon Johnson Matthey Hisun Pharmacy Cambrex Shandong Xinhua Pharmaceutical Lonza group Huahai Pharmaceutical Haerbin Pharmaceutical Group Cipla Tian Yao Lupin North East Pharmaceutical Albemarle Shandong Lukang Pharmaceutical Jiangsu Hengrui Medicine By Types: Synthetic API Biotech API Other By Applications: Chemical Deodorant Dailylife Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Active Pharmaceutical Ingredient Revenue 1.5 Market Analysis by Type 1.5.1 Global Active Pharmaceutical Ingredient Market Size Growth Rate by Type: 2021 VS 2027 1.5.2 Synthetic API 1.5.3 Biotech API 1.5.4 Other 1.6 Market by Application 1.6.1 Global Active Pharmaceutical Ingredient Market Share by Application: 2022-2027 1.6.2 Chemical 1.6.3 Deodorant 1.6.4 Dailylife 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Active Pharmaceutical Ingredient Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter’s Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Active Pharmaceutical Ingredient Market Players Profiles 3.1 Teva 3.1.1 Teva Company Profile 3.1.2 Teva Active Pharmaceutical Ingredient Product Specification 3.1.3 Teva Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.2 Novartis 3.2.1 Novartis Company Profile 3.2.2 Novartis Active Pharmaceutical Ingredient Product Specification 3.2.3 Novartis Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.3 Pfizer 3.3.1 Pfizer Company Profile 3.3.2 Pfizer Active Pharmaceutical Ingredient Product Specification 3.3.3 Pfizer Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.4 Johnson & Johnson 3.4.1 Johnson & Johnson Company Profile 3.4.2 Johnson & Johnson Active Pharmaceutical Ingredient Product Specification 3.4.3 Johnson & Johnson Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 Mylan 3.5.1 Mylan Company Profile 3.5.2 Mylan Active Pharmaceutical Ingredient Product Specification 3.5.3 Mylan Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 North China Pharmaceutical Group 3.6.1 North China Pharmaceutical Group Company Profile 3.6.2 North China Pharmaceutical Group Active Pharmaceutical Ingredient Product Specification 3.6.3 North China Pharmaceutical Group Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.7 Dr. Reddy’s Laboratories 3.7.1 Dr. Reddy’s Laboratories Company Profile 3.7.2 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Product Specification 3.7.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.8 Roche 3.8.1 Roche Company Profile 3.8.2 Roche Active Pharmaceutical Ingredient Product Specification 3.8.3 Roche Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.9 Aurobindo pharma 3.9.1 Aurobindo pharma Company Profile 3.9.2 Aurobindo pharma Active Pharmaceutical Ingredient Product Specification 3.9.3 Aurobindo pharma Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.10 Sun Pharmaceutical Industries 3.10.1 Sun Pharmaceutical Industries Company Profile 3.10.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Product Specification 3.10.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.11 Boehringer Ingelheim GmbH 3.11.1 Boehringer Ingelheim GmbH Company Profile 3.11.2 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Product Specification 3.11.3 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.12 Bayer 3.12.1 Bayer Company Profile 3.12.2 Bayer Active Pharmaceutical Ingredient Product Specification 3.12.3 Bayer Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.13 BASF 3.13.1 BASF Company Profile 3.13.2 BASF Active Pharmaceutical Ingredient Product Specification 3.13.3 BASF Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.14 DSM 3.14.1 DSM Company Profile 3.14.2 DSM Active Pharmaceutical Ingredient Product Specification 3.14.3 DSM Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.15 Zhejiang Medicine 3.15.1 Zhejiang Medicine Company Profile 3.15.2 Zhejiang Medicine Active Pharmaceutical Ingredient Product Specification 3.15.3 Zhejiang Medicine Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.16 Biocon 3.16.1 Biocon Company Profile 3.16.2 Biocon Active Pharmaceutical Ingredient Product Specification 3.16.3 Biocon Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.17 Johnson Matthey 3.17.1 Johnson Matthey Company Profile 3.17.2 Johnson Matthey Active Pharmaceutical Ingredient Product Specification 3.17.3 Johnson Matthey Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.18 Hisun Pharmacy 3.18.1 Hisun Pharmacy Company Profile 3.18.2 Hisun Pharmacy Active Pharmaceutical Ingredient Product Specification 3.18.3 Hisun Pharmacy Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.19 Cambrex 3.19.1 Cambrex Company Profile 3.19.2 Cambrex Active Pharmaceutical Ingredient Product Specification 3.19.3 Cambrex Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.20 Shandong Xinhua Pharmaceutical 3.20.1 Shandong Xinhua Pharmaceutical Company Profile 3.20.2 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Product Specification 3.20.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.21 Lonza group 3.21.1 Lonza group Company Profile 3.21.2 Lonza group Active Pharmaceutical Ingredient Product Specification 3.21.3 Lonza group Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.22 Huahai Pharmaceutical 3.22.1 Huahai Pharmaceutical Company Profile 3.22.2 Huahai Pharmaceutical Active Pharmaceutical Ingredient Product Specification 3.22.3 Huahai Pharmaceutical Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.23 Haerbin Pharmaceutical Group 3.23.1 Haerbin Pharmaceutical Group Company Profile 3.23.2 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Product Specification 3.23.3 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.24 Cipla 3.24.1 Cipla Company Profile 3.24.2 Cipla Active Pharmaceutical Ingredient Product Specification 3.24.3 Cipla Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.25 Tian Yao 3.25.1 Tian Yao Company Profile 3.25.2 Tian Yao Active Pharmaceutical Ingredient Product Specification 3.25.3 Tian Yao Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.26 Lupin 3.26.1 Lupin Company Profile 3.26.2 Lupin Active Pharmaceutical Ingredient Product Specification 3.26.3 Lupin Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.27 North East Pharmaceutical 3.27.1 North East Pharmaceutical Company Profile 3.27.2 North East Pharmaceutical Active Pharmaceutical Ingredient Product Specification 3.27.3 North East Pharmaceutical Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.28 Albemarle 3.28.1 Albemarle Company Profile 3.28.2 Albemarle Active Pharmaceutical Ingredient Product Specification 3.28.3 Albemarle Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.29 Shandong Lukang Pharmaceutical 3.29.1 Shandong Lukang Pharmaceutical Company Profile 3.29.2 Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Product Specification 3.29.3 Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.30 Jiangsu Hengrui Medicine 3.30.1 Jiangsu Hengrui Medicine Company Profile 3.30.2 Jiangsu Hengrui Medicine Active Pharmaceutical Ingredient Product Specification 3.30.3 Jiangsu Hengrui Medicine Active Pharmaceutical Ingredient Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global Active Pharmaceutical Ingredient Market Competition by Market Players 4.1 Global Active Pharmaceutical Ingredient Production Capacity Market Share by Market Players (2016-2021) 4.2 Global Active Pharmaceutical Ingredient Revenue Market Share by Market Players (2016-2021) 4.3 Global Active Pharmaceutical Ingredient Average Price by Market Players (2016-2021) 5 Global Active Pharmaceutical Ingredient Production by Regions (2016-2021) 5.1 North America 5.1.1 North America Active Pharmaceutical Ingredient Market Size (2016-2021) 5.1.2 Active Pharmaceutical Ingredient Key Players in North America (2016-2021) 5.1.3 North America Active Pharmaceutical Ingredient Market Size by Type (2016-2021) 5.1.4 North America Active Pharmaceutical Ingredient Market Size by Application (2016-2021) 5.2 East Asia 5.2.1 East Asia Active Pharmaceutical Ingredient Market Size (2016-2021) 5.2.2 Active Pharmaceutical Ingredient Key Players in East Asia (2016-2021) 5.2.3 East Asia Active Pharmaceutical Ingredient Market Size by Type (2016-2021) 5.2.4 East Asia Active Pharmaceutical Ingredient Market Size by Application (2016-2021) 5.3 Europe 5.3.1 Europe Active Pharmaceutical Ingredient Market Size (2016-2021) 5.3.2 Active Pharmaceutical Ingredient Key Players in Europe (2016-2021) 5.3.3 Europe Active Pharmaceutical Ingredient Market Size by Type (2016-2021) 5.3.4 Europe Active Pharmaceutical Ingredient Market Size by Application (2016-2021) 5.4 South Asia 5.4.1 South Asia Active Pharmaceutical Ingredient Market Size (2016-2021) 5.4.2 Active Pharmaceutical Ingredient Key Players in South Asia (2016-2021) 5.4.3 South Asia Active Pharmaceutical Ingredient Market Size by Type (2016-2021) 5.4.4 South Asia Active Pharmaceutical Ingredient Market Size by Application (2016-2021) 5.5 Southeast Asia 5.5.1 Southeast Asia Active Pharmaceutical Ingredient Market Size (2016-2021) 5.5.2 Active Pharmaceutical Ingredient Key Players in Southeast Asia (2016-2021) 5.5.3 Southeast Asia Active Pharmaceutical Ingredient Market Size by Type (2016-2021) 5.5.4 Southeast Asia Active Pharmaceutical Ingredient Market Size by Application (2016-2021) 5.6 Middle East 5.6.1 Middle East Active Pharmaceutical Ingredient Market Size (2016-2021) 5.6.2 Active Pharmaceutical Ingredient Key Players in Middle East (2016-2021) 5.6.3 Middle East Active Pharmaceutical Ingredient Market Size by Type (2016-2021) 5.6.4 Middle East Active Pharmaceutical Ingredient Market Size by Application (2016-2021) 5.7 Africa 5.7.1 Africa Active Pharmaceutical Ingredient Market Size (2016-2021) 5.7.2 Active Pharmaceutical Ingredient Key Players in Africa (2016-2021) 5.7.3 Africa Active Pharmaceutical Ingredient Market Size by Type (2016-2021) 5.7.4 Africa Active Pharmaceutical Ingredient Market Size by Application (2016-2021) 5.8 Oceania 5.8.1 Oceania Active Pharmaceutical Ingredient Market Size (2016-2021) 5.8.2 Active Pharmaceutical Ingredient Key Players in Oceania (2016-2021) 5.8.3 Oceania Active Pharmaceutical Ingredient Market Size by Type (2016-2021) 5.8.4 Oceania Active Pharmaceutical Ingredient Market Size by Application (2016-2021) 5.9 South America 5.9.1 South America Active Pharmaceutical Ingredient Market Size (2016-2021) 5.9.2 Active Pharmaceutical Ingredient Key Players in South America (2016-2021) 5.9.3 South America Active Pharmaceutical Ingredient Market Size by Type (2016-2021) 5.9.4 South America Active Pharmaceutical Ingredient Market Size by Application (2016-2021) 5.10 Rest of the World 5.10.1 Rest of the World Active Pharmaceutical Ingredient Market Size (2016-2021) 5.10.2 Active Pharmaceutical Ingredient Key Players in Rest of the World (2016-2021) 5.10.3 Rest of the World Active Pharmaceutical Ingredient Market Size by Type (2016-2021) 5.10.4 Rest of the World Active Pharmaceutical Ingredient Market Size by Application (2016-2021) 6 Global Active Pharmaceutical Ingredient Consumption by Region (2016-2021) 6.1 North America 6.1.1 North America Active Pharmaceutical Ingredient Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Active Pharmaceutical Ingredient Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Active Pharmaceutical Ingredient Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Active Pharmaceutical Ingredient Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Active Pharmaceutical Ingredient Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Active Pharmaceutical Ingredient Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Active Pharmaceutical Ingredient Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Active Pharmaceutical Ingredient Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Active Pharmaceutical Ingredient Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Active Pharmaceutical Ingredient Consumption by Countries 7 Global Active Pharmaceutical Ingredient Production Forecast by Regions (2022-2027) 7.1 Global Forecasted Production of Active Pharmaceutical Ingredient (2022-2027) 7.2 Global Forecasted Revenue of Active Pharmaceutical Ingredient (2022-2027) 7.3 Global Forecasted Price of Active Pharmaceutical Ingredient (2022-2027) 7.4 Global Forecasted Production of Active Pharmaceutical Ingredient by Region (2022-2027) 7.4.1 North America Active Pharmaceutical Ingredient Production, Revenue Forecast (2022-2027) 7.4.2 East Asia Active Pharmaceutical Ingredient Production, Revenue Forecast (2022-2027) 7.4.3 Europe Active Pharmaceutical Ingredient Production, Revenue Forecast (2022-2027) 7.4.4 South Asia Active Pharmaceutical Ingredient Production, Revenue Forecast (2022-2027) 7.4.5 Southeast Asia Active Pharmaceutical Ingredient Production, Revenue Forecast (2022-2027) 7.4.6 Middle East Active Pharmaceutical Ingredient Production, Revenue Forecast (2022-2027) 7.4.7 Africa Active Pharmaceutical Ingredient Production, Revenue Forecast (2022-2027) 7.4.8 Oceania Active Pharmaceutical Ingredient Production, Revenue Forecast (2022-2027) 7.4.9 South America Active Pharmaceutical Ingredient Production, Revenue Forecast (2022-2027) 7.4.10 Rest of the World Active Pharmaceutical Ingredient Production, Revenue Forecast (2022-2027) 7.5 Forecast by Type and by Application (2022-2027) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027) 7.5.2 Global Forecasted Consumption of Active Pharmaceutical Ingredient by Application (2022-2027) 8 Global Active Pharmaceutical Ingredient Consumption Forecast by Regions (2022-2027) 8.1 North America Forecasted Consumption of Active Pharmaceutical Ingredient by Country 8.2 East Asia Market Forecasted Consumption of Active Pharmaceutical Ingredient by Country 8.3 Europe Market Forecasted Consumption of Active Pharmaceutical Ingredient by Countriy 8.4 South Asia Forecasted Consumption of Active Pharmaceutical Ingredient by Country 8.5 Southeast Asia Forecasted Consumption of Active Pharmaceutical Ingredient by Country 8.6 Middle East Forecasted Consumption of Active Pharmaceutical Ingredient by Country 8.7 Africa Forecasted Consumption of Active Pharmaceutical Ingredient by Country 8.8 Oceania Forecasted Consumption of Active Pharmaceutical Ingredient by Country 8.9 South America Forecasted Consumption of Active Pharmaceutical Ingredient by Country 8.10 Rest of the world Forecasted Consumption of Active Pharmaceutical Ingredient by Country 9 Global Active Pharmaceutical Ingredient Sales by Type (2016-2027) 9.1 Global Active Pharmaceutical Ingredient Historic Market Size by Type (2016-2021) 9.2 Global Active Pharmaceutical Ingredient Forecasted Market Size by Type (2022-2027) 10 Global Active Pharmaceutical Ingredient Consumption by Application (2016-2027) 10.1 Global Active Pharmaceutical Ingredient Historic Market Size by Application (2016-2021) 10.2 Global Active Pharmaceutical Ingredient Forecasted Market Size by Application (2022-2027) 11 Global Active Pharmaceutical Ingredient Manufacturing Cost Analysis 11.1 Active Pharmaceutical Ingredient Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredient 12 Global Active Pharmaceutical Ingredient Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Active Pharmaceutical Ingredient Distributors List 12.3 Active Pharmaceutical Ingredient Customers 12.4 Active Pharmaceutical Ingredient Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Related reports
Non-Hodgkin Lymphoma Therapeutics Market
$2000-$6000
Acrylic Teeth Market
$3600-$7000